Company / Income Tax
Protagonist Therapeutics, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$838.0K
FY2025
5-year range
$0 / $4.2M
FY2021-FY2025
Trend
-80.1%
vs FY2024
Sector context
#78 of 204
Health Care
What the data says
At $838,000, Protagonist Therapeutics, Inc.'s income tax ranks #127 of 204 in the Health Care sector. Income Tax has fluctuated over the past 10 years, ranging from -$799,000 in FY2018 to $4M in FY2024.
Based on SEC 10-K filings.
$838,000 in FY2025 with a 5-year CAGR of -8.5%.
Increased from $0 to $838,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -8.5%
- 10-Year CAGR
- -
Sector benchmark
#127 of 204 in Health CareTop 62% of 204This company $838.0K Sector average $118.7M
▼
-99.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -8.5%, indicating a declining trend.
- In FY2025, income tax decreased 80.1% year-over-year.
- Ranks #78 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $838.0K | -80.1% |
| FY2024 | $4.2M | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | $0 | -100.0% |
| FY2020 | $1.3M | +288.9% |
| FY2019 | -$691.0K | +13.5% |
| FY2018 | -$799.0K | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026